While COL5A2 has been traditionally studied in the context of connective tissue disorders, recent studies have begun to uncover its oncogenic roles in cancers such as ovarian cancer and non-small cell lung cancer (NSCLC) [75, 76]. This evidence concerns the gene COL5A2 and ovarian cancer.